SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-212577
Filing Date
2022-08-04
Accepted
2022-08-04 16:33:48
Documents
13
Period of Report
2022-08-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d308379d8k.htm   iXBRL 8-K 35715
  Complete submission text file 0001193125-22-212577.txt   194660

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alna-20220804.xsd EX-101.SCH 3247
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alna-20220804_def.xml EX-101.DEF 13822
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20220804_lab.xml EX-101.LAB 22709
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20220804_pre.xml EX-101.PRE 14680
7 EXTRACTED XBRL INSTANCE DOCUMENT d308379d8k_htm.xml XML 5211
Mailing Address 142 -F NORTH ROAD, SUITE 150 SUDBURY MA 01776
Business Address 142 -F NORTH ROAD, SUITE 150 SUDBURY MA 01776 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 221137216
SIC: 2836 Biological Products, (No Diagnostic Substances)